State Street(R) SPDR(R) Portfolio Developed World ex-US ETF
SPDR INDEX SHARES FUNDS · Series S000014038 · 1 share classes
data updated 2026-09-08
Fund profile
As filed in the prospectus · 2026 Q1
The State Street SPDR Portfolio Developed World ex-US ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index based upon the developed world (ex-US) equity markets.
The fund tracks the S&P Developed Ex-U.S. BMI Index, a float-adjusted market-capitalization-weighted index of publicly traded companies in developed markets outside the United States, using a sampling strategy that may hold a subset of index securities or substantially all of them depending on fund size and other factors. Because the fund employs sampling rather than full replication, its returns may diverge from the index. The fund may concentrate its assets in particular industries or countries to the extent the index itself does.
| Share class | Expense ratio |
|---|---|
| SPDW | 0.03% |
Portfolio turnover 3.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.42% |
| Cash & short-term | 1.93% |
| Derivatives | 0.00% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Telecom Italia SpA/Milano, Ascendis Pharma A/S, Thomson Reuters Corp, Wise Group PLC, Swissquote Group Holding SA, SIMMTECH Co Ltd, Jeju Semiconductor Corp, Sanil Electric Co Ltd
Largest exited: Banca Popolare di Sondrio SPA, Thomson Reuters Corp, Ascendis Pharma A/S, Telecom Italia SpA/Milano, Carnival PLC, Millicom International Cellular SA, Swissquote Group Holding SA, Wise PLC
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | Samsung Electronics Co Ltd | 2.96% | $5,390.00 | $1.19B | 221.5K |
| — | SK hynix Inc | 2.79% | $1,710.45 | $1.12B | 657.4K |
| — | ASML Holding NV | 2.28% | $1,968.08 | $917.74M | 466.3K |
| GVMXX | State Street Global AdvisorsGVMXX | 1.93% | — | $778.77M | — |
| — | HSBC Holdings PLC | 0.97% | $18.99 | $391.40M | 20.6M |
| — | AstraZeneca PLC | 0.87% | $187.14 | $349.11M | 1.9M |
| — | Roche Holding AG | 0.86% | $412.57 | $348.23M | 844.0K |
| RY | Royal Bank of CanadaRY | 0.86% | $207.00 | $347.99M | 1.7M |
| — | Novartis AG | 0.86% | $156.92 | $346.83M | 2.2M |
| — | Nestle SA | 0.80% | $102.99 | $321.72M | 3.1M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 15.19% of net assets, top 25 24.02%, across 2.4K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free